Wk2 Diabetes Drugs Flashcards
Main MOA is inhibiting gluconeogenesis but not fully known:
Metformin
Reduces hepatic uptake of gluconeogenic substrates:
What side effect does this cause?
Metformin
lactate –> lactic acidosis
Systemic effect of Metformin:
increases insulin sensitivity (tyrosine kinase)
reduces lipolysis
reduces glucose absorption from SI
Binds SUR1 subunit of K+/ATP channel:
**How does this increase insulin secretion?
Glimepride
**closes channel –> DEPOLARIZES cell –> increases Ca++ –> induces fusing of insulin vesicles
Slide 6….
**this is a big one!!!
GLP-1 analog:
Exenatide
How does GLP-1 analog work?
Activates Adenyl Cyclase –> increased cAMP –> increased Ca++ –> increased insulin secretion
DPP-IV inhibitor:
Sitagliptin
How does Sitagliptin work?
inhibits DDP-IV –> prevents degradation of GLP-1 and GIP
K+ channel blockers:
–glinides
repaglinide, nataglinide
Two drugs that block K+ channel:
Glimepiride
–glinides
**need some beta cell activity to work
a-glucosidase inhibitors:
Acarbose
Miglitol
amylin analog:
Pramlinitide
How does Pramlintide work?
amylin analog
- inhibits glucagon synthesis
- inhibits gluconeogenesis in liver
- delays gatric emptying
- increases satiety
PPARgamma receptor agonist:
TZDs
–litazones